Neutrophilic dermatoses: A review of current treatment options

American Journal of Clinical Dermatology

Volumn 10, Issue 5, 2009, Pages 301-312

  Cohen, Philip R ^a,b,c  

^a UNIVERSITY OF HOUSTON   (United States)

^b UNIVERSITY OF TEXAS   (United States)

^c MD Anderson Cancer Center ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADALIMUMAB; ALEFACEPT; AZATHIOPRINE; CALCINEURIN INHIBITOR; CLOBETASOL PROPIONATE; CLOFAZIMINE; COLCHICINE; CORTICOSTEROID; CYCLOPHOSPHAMIDE; CYCLOSPORIN; DAPSONE; ETANERCEPT; ETRETIN; ETRETINATE; IMMUNOGLOBULIN; INDOMETACIN; INFLIXIMAB; METHOTREXATE; METHYLPREDNISOLONE; METHYLPREDNISOLONE SODIUM SUCCINATE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; POTASSIUM IODIDE; PREDNISONE; RECOMBINANT INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; RETINOIC ACID; SULFAPYRIDINE; THALIDOMIDE; TRIAMCINOLONE ACETONIDE; TUMOR NECROSIS FACTOR ALPHA INHIBITOR;

ACUTE FEBRILE NEUTROPHILIC DERMATOSIS; ACUTE GRANULOCYTIC LEUKEMIA; ANTIBACTERIAL ACTIVITY; AUTOIMMUNE DISEASE; COMBINATION CHEMOTHERAPY; CORTICOSTEROID THERAPY; DERMIS; DISEASE ASSOCIATION; DRUG EFFICACY; ENTERITIS; EPIDERMIS; ERYTHEMA; FEVER; GASTROINTESTINAL INFECTION; HEMATOLOGIC MALIGNANCY; HISTOPATHOLOGY; HUMAN; HYPERBARIC OXYGEN; INFLAMMATORY CELL; LEUKOCYTOSIS; LYMPHOPROLIFERATIVE DISEASE; MONOTHERAPY; MORNING DOSAGE; MORPHOLOGY; NAUSEA AND VOMITING; NEUTROPHIL CHEMOTAXIS; NEUTROPHIL COUNT; PHOTOTHERAPY; PLASMAPHERESIS; PRIORITY JOURNAL; PUSTULE; PYODERMA GANGRENOSUM; REVIEW; RHEUMATOID ARTHRITIS; SINGLE DRUG DOSE; SKIN MANIFESTATION; SKIN ULCER; SOLID TUMOR; SOMNOLENCE; STAPHYLOCOCCUS AUREUS; SUBCORNEAL PUSTULAR DERMATOSIS; T LYMPHOCYTE ACTIVATION; ULTRAVIOLET A RADIATION; UPPER RESPIRATORY TRACT INFECTION;

ANTI-INFLAMMATORY AGENTS; HUMANS; NEUTROPHILS; PYODERMA GANGRENOSUM; SKIN DISEASES, VESICULOBULLOUS; SWEET SYNDROME;

EID: 68949101331     PISSN: 11750561     EISSN: 11791888     Source Type: Journal    
DOI: 10.2165/11310730-000000000-00000     Document Type: Review

References (64)

1. Cohen PR. Neutrophilic dermatoses occurring in oncology patients. Int J Dermatol 2007; 46: 106-111
2. Callen JP. Neutrophilic dermatoses. Dermatol Clin 2002; 20: 409-419
3. Cohen PR. Sweet's syndrome: a comprehensive review of an acute febrile neutrophilic dermatosis. Orphanet J Rare Dis 2007; 2: 34
4. Cohen PR, Almeida L, Kurzrock R. Acute febrile neutrophilic dermatosis. Am Fam Physician 1989; 39 (3): 199-204
5. Cohen PR, Kurzrock R. Diagnosing the Sweet syndrome. Ann Intern Med 1989; 110: 573-574
6. Cohen PR, Kurzrock R. Sweet's syndrome: a neutrophilic dermatosis classically associated with acute onset and fever. Clin Dermatol 2000; 18: 265-282
7. Cohen PR, Kurzrock R. The pathogenesis of Sweet's syndrome [letter]. J Am Acad Dermatol 1991; 25: 734
8. Cohen PR, Kurzrock R. Sweet's syndrome revisited: a review of disease concepts. Int J Dermatol 2003; 42: 761-778
9. Cohen PR. Preganancy-associated Sweet's syndrome: world literature review. Obstet Gynecol Survey 1993; 48: 584-587
10. Satra KH, Zalka A, Cohen PR, et al. Sweet's syndrome and pregnancy. J Am Acad Dermatol 1994; 30: 297-300
11. Cohen PR, Kurzrock R. Sweet's syndrome and cancer. Clin Dermatol 1993; 11: 149-157
12. Cohen PR, Talpaz M, Kurzrock R. Malignancy-associated Sweet's syndrome: review of the world literature. J Clin Oncol 1988; 6: 1887-1897
13. Cohen PR, Kurzrock R. Chonic myelogenous leukemia and Sweet syndrome. Am J Hematol 1989; 32: 134-137
14. Cohen PR, Kurzrock R. Paraneoplastic Sweet's syndrome. Emerg Med 1994; 26 (2): 37-38
15. Cohen PR, Kurzrock R. Sweet's syndrome and malignancy. Am J Med 1987; 82: 1220-1226
16. Cohen PR, Holder WR, Tucker SB, et al. Sweet syndrome in patients with solid tumors. Cancer 1993; 72: 2723-2731
17. Walker DC, Cohen PR. Trimethoprim-sulfamethoxazole-associated acute febrile neutrophilic dermatosis: case report and review of drug-induced Sweet's syndrome. J Am Acad Dermatol 1996; 34: 918-923
18. Cohen PR. Skin lesions of Sweet syndrome and its dorsal hand variant contain vasculitis: an oxymoron or an epiphenomenon? Arch Dermatol 2002; 138: 400-403
19. Cohen PR. Subcutaneous Sweet's syndrome: a variant of acute febrile neutrophilic dermatosis that is included in the histopathologic differential diagnosis of neutrophilic panniculitis. J Am Acad Dermatol 2005; 52: 927-928
20. Cohen PR, Holder WR, Rapini RP. Concurrent Sweet's syndrome and erythema nodosum: a report, world literature review and mechanism of pathogenesis. J Rheumatol 1992; 19: 814-820
21. Cohen PR. Sweet's syndrome presenting as conjunctivitis. Arch Ophthalmol 1993; 111: 587-588
22. Cohen PR, Kurzrock R. Extracutaneous manifestations of Sweet's syndrome: steroid-responsive culture-negative pulmonary lesions [letter]. Am Rev Respir Dis 1992; 146: 269
23. Cohen PR. Sweet syndrome and erythema nodosum [letter]. South Med J 2007; 100: 1057-1058
24. Cohen PR. Sweet's syndrome and relapsing polychondritis: is their appearance in the same patient a coincidental occurrence or a bona fide association of these conditions? Int J Dermatol 2004; 43: 772-777
25. Callen JP, Jackson JM. Pyoderma gangrenosum: an update. Rheum Dis Clin North Am 2007; 33: 787-803
26. Brooklyn T, Dunnill G, Probert C. Diagnosis and treatment of pyoderma gangrenosum. BMJ 2006; 333: 181-184
27. Wollina U. Pyoderma gangrenosum: a review. Orphanet J Rare Dis 2007; 2: 19
28. Powell FC, Collins S. Pyoderma gangrenosum. Clin Dermatol 2000; 18:283-293
29. Crowson AN, Mihm Jr MC, Magro C. Pyoderma gangrenosum: a review. J Cutan Pathol 2003; 30: 97-107
30. Reed J, Wilkinson J. Subcorneal pustular dermatosis. Clin Dermatol 2000; 18: 301-313
31. Bordignon M, Zattra E, Montesco MC, et al. Subcorneal pustular dermatosis (Sneddon-Wilkinson disease) with absence of desmoglein 1 and 3 antibodies case report and literature review. Am J Clin Dermatol 2008; 9: 51-55
32. Cheng S, Edmonds E, Ben-Gashir M, et al. Subcorneal pustular dermatosis: 50 years on. Clin Exp Dermatol 2008; 33: 229-233
33. Castro-Fernandez M, Sanchez-Munos D, Ruiz-Granados E, et al. Coexistence of pyoderma gangrenosum and Sweet's syndrome in a patient with ulcerative colitis [letter]. Am J Gastroenterol 2007; 102: 2865-2866
34. Caughman W, Stern R, Haynes H. Neutrophilic dermatosis of myeloproli-ferative disorders. J Am Acad Dermatol 1983; 9: 751-758
35. Lear JT, Byrne JPH. Bullous pyoderma gangrenosum, Sweet's syndrome and malignancy [letter]. Br J Dermatol 1997; 136: 296-297
36. Salmon P, Rademaker M, Edwards L. A continuum of neutrophilic disease occurring in a patient with ulcerative colitis. Australas J Dermatol 1998; 39: 116-118
37. Wilson DM, John GR, Callen JP. Peripheral ulcerative keratitis: an extra-cutaneous neutrophilic disorder. Report of a patient with rheumatoid arthritis, pustular vasculitis, pyoderma gangrenosum, and Sweet's syndrome with an excellent response to cyclosporine therapy. J Am Acad Dermatol 1999; 40: 331-334
38. Marsden JR, Millard LG. Pyoderma gangrenosum, subcorneal pustular der-matosis and IgA paraproteinaemia. Br J Dermatol 1986; 114: 125-129
39. Kohl PK, Hartschuh W, Tilgen W, et al. Pyoderma gangrenosum followed by subcorneal pustular dermatosis in a patient with IgA paraproteinemia. J Am Acad Dermatol 1991; 24: 325-328
40. Cartier H, Plantin P, Leroy JP, et al. Pyoderma gangrenosum, subcorneal IgA pustulosis and recurrent neutrophilic pleural and pulmonary disease in a patient with IgA gammopathy. Ann Dermatol Venereol (Paris) 1995; 122: 97-101
41. Freire Murgueytio P, Allegue F, Martin Gonzalez M, et al. Gangrenous pyoderma associated with subcorneal pustular dermatosis (Sneddon-Wilkinson disease). Med Cutan Ibero Lat Am 1989; 17: 105-109
42. Venning VA, Ryan TJ. Subcorneal pustular dermatosis followed by pyoderma gangrenosum. Br J Dermatol 1986; 115: 117-118
43. Puechguiral-Renaud I, Carpentier O, Piette F, et al. Subcorneal pustulosis and pyoderma gangrenosum associated with a biclonal gammopathy. Eur J Dermatol 2006; 16: 687-690
44. Scerri L, Zaki I, Allen BR. Pyoderma gangrenosum and subcorneal pustular dermatosis, without monoclonal gammopathy. Br J Dermatol 1994; 130: 398-399
45. Wolff K. Subcorneal pustulose dermatose (Sneddon-Wilkinson): pyoderma gangrenosum mit IgA paraproteinamie [abstract]. Dermatol Wocherschrift 1971; 157: 842
46. Dallot A, Decazes JM, Drouault Y, et al. Subcorneal pustular dermatosis (Sneddon-Wilkinson disease) with amicrobial lymph node suppuration and aseptic spleen abscess. Br J Dermatol 1988; 119: 803-807
47. Cohen PR, Kurzrock R. Sweet's syndrome: a review of current treatment options. Am J Clin Dermatol 2002; 3: 117-131
48. Cohen PR, Holder WR. Pentoxifylline for Sweet's syndrome. J Am Acad Dermatol 1995; 32: 533-534
49. Cohen PR, Kurzrock R. Treatment of Sweet's syndrome [letter]. Am J Med 1990; 89: 396
50. Delluc A, Limal N, Puechal X, et al. Efficacy of anakinra, an IL1 receptor antagonist, in refractory Sweet syndrome. Ann Rheum Dis 2008; 67: 278-279
51. Reichrath J, Bens G, Bonowitz A, et al. Treatment recommendations for pyoderma gangrenosum: an evidence-based review of the literature based on more than 350 patients. J Am Acad Dermatol 2005; 53: 273-283
52. Gettler S, Rothe M, Grin C, et al. Optimal treatment of pyoderma gangrenosum. Am J Clin Dermatol 2003; 4: 597-608
53. Fonder MA, Cummins DL, Ehst BD, et al. Adalimumab therapy for recalcitrant pyoderma gangrenosum. J Burns Wounds 2006; 5: e8
54. Juillerat P, Christen-Zach S, Troillet F-X, et al. Infliximab for the treatment of disseminated pyoderma gangrenosum associated with ulcerative colitis: case report and literature review. Dermatology 2007; 215: 245-251
55. Chiba T, Isomura I, Suzuki A, et al. Topical tacrolimus therapy for pyoderma gangrenosum. J Dermatol 2005; 32: 199-203
56. Foss CE, Clark AR, Inabinet R, et al. An open-label pilot study of alefacept for the treatment of pyoderma gangrenosum. J Eur Acad Dermatol Venereol 2008 Aug; 22: 943-949
57. Meyer N, Ferraro V, Mignard M-H, et al. Pyoderma gangrenosum treated with high-dose intravenous immunoglobulins: two cases and review of the literature. Clin Drug Invest 2006; 26: 541-546
58. Cummins DL, Anhalt GJ, Monahan T, et al. Treatment of pyoderma gangrenosum with intravenous immunoglobulin. Br J Dermatol 2007; 157: 1235-1239
59. Wenzel J, Gerdsen R, Phillipp-Dormston W, et al. Topical treatment of pyoderma gangrenosum. Dermatology 2002; 205: 221-223
60. Tutrone WD, Green K, Weinberg JM, et al. Pyoderma gangrenosum: dermatologic application of hyperbaric oxygen therapy. J Drugs Dermatol 2007; 6: 1214-1219
61. Marliere V, Beylot-Barry M, Beylot C, et al. Successful treatment of subcorneal pustular dermatosis (Sneddon-Wilkinson disease) by acitretin: report of a case. Dermatology 1999; 199: 153-156
62. Voigtlander C, Luftl M, Schuler G, et al. Infliximab (anti-tumor necrosis factor alpha antibody): a novel, highly effective treatment of recalcitrant subcorneal pustular dermatosis (Sneddon-Wilkinson disease). Arch Dermatol 2001; 137: 1571-1574
63. Bonifati C, Trento E, Cordiali Fei P, et al. Early but not lasting improvement of recalcitrant subcorneal pustular dermatosis (Sneddon-Wilkinson disease) after infliximab therapy: relationships with variations in cytokine levels in suction blister fluids. Clin Exp Dermatol 2005; 30: 662-665
64. Kawaguchi M, Mitsuhashi Y, Kondo S. A case of subcorneal pustular dermatosis treated with tacalcitol (1alpha, 24-dihydroxyvitaminD3). J Dermatol 2000; 27: 669-672